PROTAC FAK degrader 1 is primarily used in biomedical research to study the role of focal adhesion kinase (FAK) in cellular processes. It is designed to selectively degrade FAK, a protein involved in cell adhesion, migration, and survival, making it a valuable tool for investigating cancer biology and metastasis. By targeting FAK for degradation, it helps researchers understand the protein's function and its potential as a therapeutic target in diseases like cancer. This compound is particularly useful in preclinical studies to evaluate the effects of FAK inhibition on tumor growth and progression. Its application extends to drug discovery, where it aids in developing novel therapies aimed at disrupting FAK signaling pathways.